Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Return on Equity (2016 - 2025)

Firefly Neuroscience has reported Return on Equity over the past 13 years, most recently at 2.3% for Q4 2025.

  • Quarterly results put Return on Equity at 2.3% for Q4 2025, down 742.0% from a year ago — trailing twelve months through Dec 2025 was 2.3% (down 742.0% YoY), and the annual figure for FY2025 was 5.48%, down 8409.0%.
  • Return on Equity for Q4 2025 was 2.3% at Firefly Neuroscience, down from 1.95% in the prior quarter.
  • Over the last five years, Return on Equity for AIFF hit a ceiling of 6.02% in Q3 2023 and a floor of 157.29% in Q1 2023.
  • Median Return on Equity over the past 5 years was 0.16% (2023), compared with a mean of 11.03%.
  • Peak annual rise in Return on Equity hit 634bps in 2023, while the deepest fall reached -15721bps in 2023.
  • Firefly Neuroscience's Return on Equity stood at 0.1% in 2021, then crashed by -2145bps to 2.2% in 2022, then surged by 90bps to 0.22% in 2023, then surged by 2440bps to 5.12% in 2024, then plummeted by -145bps to 2.3% in 2025.
  • The last three reported values for Return on Equity were 2.3% (Q4 2025), 1.95% (Q3 2025), and 2.64% (Q2 2025) per Business Quant data.